Aldesleukin Active Not Recruiting Phase 2 Trials for Renal Cancers Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02964078Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer